Blackstone explores sale of Anthos Therapeutics -sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Goldman Sachs Positive on The Blackstone Group (BX) Following Conference
December 6, 2023 2:09 PM ESTGoldman Sachs analyst Alexander Blostein reiterated a Buy rating and $115.00 price target on The Blackstone Group (NYSE: BX)
The analyst comments "Presenters: BX's President and COO Jonathan Gray presented at the GS 2023 US Financial Services Conference this afternoon (December 6). Bottom line:... More
